Compare Adaptive Biotechnologies Corp (ADPT) vs Workiva Inc (WK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Workiva Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Workiva Inc trades at $68.83 (market cap $3.76B). The key difference: Adaptive Biotechnologies Corp and Workiva Inc are close in size by market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, Workiva Inc nearer its low. Which is the better fit depends on your goals.
| ADPT | WK | |
|---|---|---|
Market Cap | $4.04B | $3.76B |
Sector | Health | Technology |
52-Week High | $25.45 | $93.31 |
52-Week Low | $12.30 | $44.31 |
Enterprise Value | $4.10B | $3.73B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Workiva Inc
Workiva is a leading provider of cloud-based platforms for complex reporting and compliance. It enables organizations to connect and manage data across financial reporting, ESG (Environmental, Social, and Governance), and GRC (Governance, Risk, and Compliance), serving as a single source of truth for auditable, transparent disclosures to regulators and stakeholders.
Read more on WK →
